Update on latest achievements - The Royal Wolverhampton ...

royalwolverhamptonhospitals.nhs.uk

Update on latest achievements - The Royal Wolverhampton ...

ong>Updateong> on latest achievements

TrustTalk

Autumn 2010

All the latest news and development from across the Trust


Contents

1

Autumn 2010

Our latest achievements

3 Heart and Lung Centre Busiest

903 cardiac operations were performed at the

centre during 2009-2010

4 Charitable Trust Buys New Equipment

Find out how the cash has been spent to

introduce new equipment that will benefit

patients

5 New Health Service Chairman

Well known local health chief begins his four

year appointment with the Trust

5 Improvements planned for Stroke Unit

New plans set to increase capacity of the unit

through team expansion and a new physician

7 Focus on TPOT Thinking

Taking a closer look at the Productive Operating

Theatre Programme and how it works

Awards

8 PEAT Rates Trust Highly

One out of just 40 hospitals to achieve triple

excellence for maintaining a quality environment

8 Midwifery Award for Normal Childbirth

Maternity unit recognised for inspirational work

on improving local maternity services

Medical Feature

9 World Leading Cancer Research

The latest on trials that have helped put New

Cross on the map as a leading cancer centre

Latest ong>Updateong>s

11 Transforming Community Services

Achieving greater service integration through a

structured reform of community services

12 R&D Latest

An insight into the team dedicated to seeking

innovations that will help patients

13 MRSA Dispelling the Myths

Dispelling some of the myths surrounding MRSA

infection in hospitals

Staff Shout

15 Trust Midwife’s Charity Bike Ride

Midwife’s physical and mental endurance put to

the test in aid of National charity

16 Neonatal Unit Receives Donations

Special thanks to the people who’ve supported

the unit with their generous donations

16 Footy Team Tackles NHS Tournament

5-aside team represents Trust in national football

event

17 Trusts Marathon Activities for Dementia Care

Staff step up to the challenge to help raise more

money towards dementia project

18 Retail Survey Winner

Survey captures information from staff to help

shape Trust’s retail strategy

18 New Patient Care Pathway Launches

Providing the best quality care possible for

patients at the end of their life

18 New Catering Facility Opens

A £3 million investment to provide better quality

food and more choice and flexibility for patients

History

19 Florence Nightingale

Trust marks 100th anniversary of Nightingale’s

death with a look at how she influenced today’s

nursing

Have you got any stories for the next edition of

Trust Talk?

Then contact the Communications Department on

01902 695900 or email samanthaturner@nhs.net

If you require this magazine in another format please

contact the Communications Team on:

01902 695900

or would like to share your thoughts on Trust Talk.

4 15 17 19

Welcome from the

Chief Executive

Barry Picken,

Chairman

Well, it’s been a busy Summer here at the Trust and

we’ve also welcomed a new Chairman into the fold.

Barry Picken has a wealth of experience in the health

sector, having been on the Board of the Wolverhampton

PCT and as a lay assessor for the General Medical

Council. He is also a magistrate and a member of the

West Midlands Police Authority. His appointment is a

good move for us at such an exciting time of continuous

development and achievements across the Trust.

“I’m delighted to be taking up the role as chairman of

the Trust at such a challenging time,” says Barry. “In the

coming months the Hospital has to achieve Foundation

Trust status, as well as deliver the Transforming

Community Services agenda, involving the transfer

of over 1,000 staff and services from the PCT to the

Hospital.”

This Autumn issue sees more of our achievements

as a Trust, but also tells some of the stories behind

our successes, such as our cancer services, which are

renowned as a world class facility and our Heart and

Lung Centre, which is the busiest in the region. Research

and Development is another growing area for us. We

saw an income of £3.7 million generated from our

innovations last year alone.

As we go to press, we await news on our Foundation

Trust status and will continue to keep you informed on

this. We are hopeful that, by the end of this year, our

application for status will be approved. More on this will

be in our winter edition of Trust Talk.

Thanks to everyone, both our staff and our patients,

for helping make New Cross one of the best hospital

facilities around.

Enough from us now! Please enjoy reading this issue, so

we can bring you up to date with what’s happening here

in Wolverhampton

David Loughton CBE

Chief Executive

David Loughton CBE,

Chief Executive

From the top

2


Achievements

3

Heart & Lung

Centre Busiest

For the third year running, the Heart and

Lung Centre at Wolverhampton’s New

Cross Hospital is the most active cardiac

surgery unit in the West Midlands.

There are a total of four units across

the region and the Trust performed

903 cardiac operations during 2009 to

2010. Since opening in October 2004,

over 5200 cardiac operations have been

carried out – that’s an average of 72 a

month, or 864 a year.

Such a high level of activity has been

achieved without comprising the quality

of care delivered. Data from Dr Foster,

the UK's leading provider of comparative

information on health and social care

services, shows that the Heart and Lung

Centre was the best in the country. It had

the lowest relative risks of mortality and

shortest length of stay for cardiac surgery

from 2009 to 2010.

Chief Executive, David Loughton CBE,

explained why this is such a significant

achievement: “I’m immensely proud of

what the staff in the Heart and Lung

Centre have achieved since it opened.

When I took up post here, I thought the

unit may lose £10m a year. Never in my

wildest expectations did I think it would

go on to become one of the best Heart

and Lung Centres in the country. The

staff really have done a fantastic job.”

This year, the Trust once again received

an excellence rating from the Care

Quality Commission for its quality of

services.

The Heart & Lung Centre

at New Cross Hospital

For the third year running, the Heart and

Lung Centre at Wolverhampton’s New Cross

Hospital is the most active cardiac surgery unit

in the West Midlands.

Charitable Trust Buys

New Equipment

Glaucoma Laser System

Phil Parkes, Mr Isgar and Trevor Mitchel

Sun Nuclear MapCHECK2 IMRT QA System

3D Toe Imaging System

Thanks to cash from the Charitable Trust, we’ve been able to buy a range of

equipment to help provide the best possible services for our patients.

The Bioptics Digital System was introduced into the nucleus breast theatre in

May 2010. It means that x-rays of breast lesions can be taken in theatre, which

instantly produce images for analysis.

Before this, breast tissue had to be taken to the Breast Imaging Department and

hard copies of x-rays had to be returned to theatre before the operation could be

completed.

“This new x-ray equipment saves around 20 minutes per operation, in terms of

anaesthetic and operating time,” explained Tony Wilding, Directorate Manager for

Surgery and Urology.

The Bioptics equipment cost £49,750, thanks to cash from the Breast Care Action

Group Nurses Trust Fund and the Deanesly Centre Trust Fund.

“This kit was dedicated to Maureen Parkes, an enthusiastic fund raiser for breast

cancer patients in Wolverhampton, who sadly passed away before the machine

was installed,” said Tony.

Full details of other equipment purchased will appear in the Charitable Trust

Fund’s Annual Report.

Equipment funded through the Charitable Trust

Equipment Cost Funded by

Bioptics piXarray Digital System £49.750 Deanesly Trust Fund

Glaucoma Laser System £33,310

Ophthalmology Trust Fund,

League of Friends

3D TOE Imaging System £33,448 Cardiothoracic Trust Fund

Sun Nuclear MapCHECK2 IMRT

QA System

£24,000 Deanesly Trust Fund

4


Achievements

5

New Health

Service Chairman

The new Chairman of our Trust is well

known local health chief, Barry Picken.

Barry began his four year appointment

on 1 September 2010, which runs

until August 2014. The appointment

was made in accordance with the

Commissioner for Public Appointments’

Code of Practice.

Living in Wolverhampton, Barry has

been involved in healthcare in the city

since 2002, when he became a non

executive director of Wolverhampton

Primary Care Trust (PCT). He became

chair of the PCT in 2006, a role he stood

down from to take up this new post.

Mr Picken said: “I’m delighted to

be taking up the role as chairman

of the Trust at such an exciting and

challenging time. The NHS is about

to enter a period of substantial

challenge and I’m very conscious of the

responsibility of leading the Hospital

through this.”

Chief Executive, David Loughton CBE

said: “I’d like to take this opportunity

to warmly welcome Barry as our

new Chairman here at the Trust.

His experience in the community

and voluntary sectors will be really

important in supporting us to improve

services for patients.

“I’m particularly pleased because of the

reassurance it should give to the 1,000

staff that will transfer from the PCT to

the Trust, as part of the Government’s

initiative on Transforming Community

Services. We will also benefit from

the fact that Barry has a wealth of

experience in the management of these

services”.

Improvements Planned for Stroke Unit

A National audit, which monitors hospital stroke units,

puts New Cross in the top half of Acute Trusts for its

facilities and services in this specialist area.

The National Sentinel Audit for Stroke report says an

efficient service is being provided at the Trust, and also

identified areas for improvement: “Several National

initiatives have been introduced over the past year

and these have changed the standards we now need

to meet,” said Chief Executive, David Loughton CBE.

The Acceleration Improvement Programme and

brand new stroke guidelines means all Trusts

have been asked to increase the number of direct

admissions to the stroke unit. This, together with our

need to increase capacity, and make sure we have

stroke expertise here seven days a week, led us to

New Trust Chairman

Barry Picken

create an action plan to improve what we can deliver

here.”

Plans include the appointment of a new Stroke

Physician and expansion of the Community

Rehabilitation Team. Recruitment and training for

these enhancements should begin by the end of 2010.

The Trust’s Acute Stroke Unit has 23 beds. It admitted

750 patients between June 2009 and June 2010,

including people from Wolverhampton, the South

Staffordshire ‘fringe’ and referrals from Stafford and

Cannock.

“Having identified what we need to become even

better, we’re confident our stroke unit will develop

into one that our staff and the local population can be

even more proud of,” said David.

Exercise

Short

Fuse

Success!

A joint exercise with the Fire Service, to

test out plans for dealing with chemical

incidents, has been held at the Trust.

Operation Short Fuse was designed

to see how effectively we can manage

incidents of this kind and provide a

more integrated response with the fire

service.

The exercise was based on a small

explosion within a chemical store

at New Cross Hospital. The fictional

‘blast’ meant some of the chemicals

may have been exposed to 12 people

working in the stores area at the time.

Live casualties were presented to the

exercise team with the aim of rescuing

all saveable life; handing casualties on

to the hospital for decontamination

and identifying substances to influence

ongoing treatment by the medical

team. The exercise tested the Trust’s

security resilience in the event of an

incident threat. It was filmed and

photographed for use at future training

events and was an opportunity to

analyse joint working; people’s roles

and responsibilities and incident scene

management. A wide range of staff

were involved in the exercise, including

Porters, A&E Nursing & Reception,

Security and Medical Physics, who

provided support in relation to

chemicals.

“Huge thanks to everyone involved in

this exercise,” explained Diane Preston,

Head of Emergency Preparedness at

the Trust. “It certainly demonstrated

our resilience in the event of a chemical

incident and tested out our new

decontainer unit. It was really helpful

to work so closely with the fire service

and identify any issues that could arise

during an incident like this.”

6


Team Focus

"Touring staff

around the

department

to see the

results for

themselves

shows them

the real

benefits of

taking this

approach."

7

Focus on -

T-POT Thinking

Since its National launch, in

September 2009, The Productive

Operating Theatre programme,

(T-POT), has played a fundamental

role in helping theatre teams work

together more effectively.

The programme seeks to improve

the patient experience, the safety and

outcomes of surgical services and

more effective use of theatre time.

Clare Nash is the Programme’s

Manager here at the Trust: “T-POT

was officially launched to staff at

the end of July and follows the

highly successful Productive Ward

Programme. This new initiative

will focus on two of the hospital’s

theatres; Nucleus 3 and Beynon, with

plans to roll it out to the others later

on.”

‘Building Teams for Safer Care’ is

the slogan behind the programme. It

looks at how the department is doing

and what can be improved in the key

areas of: safety and reliability; patient

experience and outcome; team

performance, staff wellbeing and

value and efficiency.

A Systematic Approach

“It’s all about taking a systematic

approach,” explains Clare. “It looks

at each element and unpicks each

one, finding out where the wastage

is and stripping out any unnecessary

waste steps. It’s about smarter ways

of working and giving people the

tools to help them be more efficient

and further develop the service.”

It’s hoped that, by using this

approach, theatre teams will be in

a better position to reduce waiting

list times, reduce the extra hours

staff need to work and get through

operating lists more quickly.

Top 7 Priorities

Fifty staff attended the launch’s

visioning workshop, which included

theatre staff, support staff and

clinicians. They were tasked with

creating a list of Top 7 actions

which, in their view, would make

their working day ‘perfect.’ The list

includes things like, having enough

recovery staff, starting on time and

better scheduling. Staff then voted

on these in order of priority. They

put having all equipment and sets

ready to go top of the list. “Getting

people from all levels together was

Staff getting involved in the visioning workshop

really helpful, because it allowed

people to appreciate the issues and

the difficulties faced by their fellow

colleagues,” said Clare.

Chief Executive, David Loughton

attended the launch. He emphasised

that TPOT is about improving

working lives for the staff as well as

improving the safety and reliability

of care. It’s not about saving money.

Measurement workshops also took

place in August, where teams chose

their own local measurements based

on the Top 7 priorities.

The Benefits

The success of the Productive Ward

Programme showed how beneficial

this type of approach can be. Laura

Patrick is a Staff Nurse and found

Productive Ward incredibly useful:

“A lot of the time we couldn’t find

anything so we would re-order it. We

had a treatment room which was also

used for drug preparation. Children

undergoing treatment are already

nervous so having people coming in

and out all the time didn’t help. Now,

we have a drug preparation room

and a separate treatment room –

with no more interruptions!”

Engaging with staff is an equally

important aspect of the programme.

“Touring staff around the

department to see the results for

themselves shows them the real

benefits of taking this approach.

We’ve also linked up with several

regional hospitals to share each

other’s learning and ideas from the

programme,” said Clare.

Clinicians have been briefed at

directorate meetings and the

programme has also been featured at

Senior Managers Briefing. All staff

can access the latest updates on the

programme through the home page

of the intranet.

Joint Seminar

The Royal College of Surgeons

and the NHS Institute held a joint

seminar in September to talk about

the important role surgeons and

anaesthetists continue to play within

the programme. It highlighted how,

as the NHS enters a critical time,

surgeons and anaesthetists can

embrace the programme, be at the

forefront of quality improvements

and make a real difference for

patients and staff.

About the Team

Led by Clare Nash, the programme

team has a lead Matron and

includes a project facilitator, with

support from admin and the service

improvement team. It expects to

collect some baseline data around

sets of equipment being ready and

lists being kept to, which will help

measure the positive outcomes of the

programme.

The Productive Operation Theatre

'PEAT'

Rates Trust

Highly

Ivan Little, left and Sandra Roberts, pictured right, receive their

certificates from Chief Executive, David Loughton CBE.

Midwifery

Award for

Normal

Childbirth

The maternity unit is celebrating after winning an award

from the All-Party Parliamentary Group on Maternity

(APPGM).

The Trust was recognised in the Normality in Childbirth

category at the awards, which acknowledge inspiring or

innovative work in improving local maternity services.

They were presented at the APPGM summer reception

in July, at the Houses of Parliament.

The APPGM, which is serviced by the NCT charity, is

a cross-party group whose aim is to highlight maternity

issues within Parliament and bring together health

professionals and service users with politicians.

The team at New Cross Hospital developed a

standardised model of care for high risk women in

labour and their partners. This model aims to maximise

the opportunity for normal birth and promote a positive

birth experience.

The National Patient Safety Agency has rated the Trust

excellent in all three areas when treating patients in a

cleaner and better maintained environment.

The Patient Environment Action Team, (PEAT),

assesses all hospitals and inpatient units with 10

or more beds. The teams are made up of nurses,

matrons, doctors, catering staff, domestic service

managers, patients and the public. They scrutinise

levels of cleanliness, aspects of infection control, the

quality of the environment and the standard of the

food.

Hospitals are scored; excellent, good, acceptable,

poor or unacceptable. Wolverhampton was rated

excellent in all three PEAT categories – one of only 40

out of 1,242 hospitals to achieve this.

Divisional Manager for Estates and Facilities, Graham

Argent, explained why these ratings are so important:

“To have achieved the triple excellence rating puts us

firmly in the upper quartile of hospital performers. It’s

a real demonstration of our determination to be the

best and we’re totally committed to maintaining this

rating for the benefit of our patients.”

Estates and Facilities Manager, Ivan Little and Sandra

Roberts, Head of Hotel Services were presented

with certificates by the Trust’s Chief Executive, in

recognition of their efforts towards this.

PEAT scores are conducted annually, with assessments

carried out between January and March.

The birth environment has been adapted to be

conductive to normal birth, with a range of birthing aids

including birthing balls and stools. This information will

be given to all members of the maternity team over the

next few months.

Dr Dan Poulter MP, Chair of the APPGM, said: “It’s a

privilege to present these awards to such deserving and

exemplary maternity units. The winning units’ innovative

work will be an inspiration to other Trusts.”

Awards

Receiving their award are Matron Tracy Palmer and midwives Lyndsay Durkin, Joanne Ridley and Cath Denyer.

Photograph supplied by Lyndsay Durkin.

8


Medical Feature

9

World leading Cancer

Research at New Cross

Cancer of the oesophagus has increased,

with deaths from the disease

rising by 50% over the last 20 years.

Professor David Ferry

This growth in oesophageal cancer is the largest

increase of any cancer in the Western world.

Last year, there were over 16,000 cases. 13,000

oesophagogastric cancer deaths make this the third

leading cause of cancer death in the UK – causing

more deaths than breast cancer.

There are no useful screening tests on the horizon and

less than 10% of patients are cured by surgery, so the

need for new medicines is hugely important. Upper

gastrointestinal cancers is one of the ‘Cinderella’ areas

of cancer care, but recent advances in research are

changing this.

Oesopohagus

COG trial

Getinib

Targets EGF receptor

Stomach

GRANITE trial

Everolimus

Targets mTOR

Gefitinib is a new drug. It could help patients with

advanced incurable oesophageal cancer. Gefitinib

works by inhibiting growth receptors on the surface

of cells, leading to cell death and shrinkage of cancers.

Gefitinib is taken orally, once a day and although it

can cause teenage spots and sometimes diarrhoea,

it doesn’t cause the traditional side effects that

chemotherapy does. Gefitinib is one of the new

drugs at the forefront of what is called personalised

medicine.

Clinical research into gefitinib began in 1999, when

Professor David Ferry and his colleagues presented

the first phase one clinical trial data on Gefitinib

at the American Society of Clinical Oncology. This

drug became widely used in lung cancer, but in

2007, Professor Ferry published the effectiveness of

Gefitinib in a phase II clinical trial. All the patients in

this trial were treated at New Cross Hospital, but many

were referred from consultants at other hospitals. This

led to the launch of phase III, the Cancer Oesophagus

Gefitinib (COG) trial, led by Professor Ferry and run

from the trials unit at Oxford University.

Cancer Research UK (CRUK) awarded grants of £500

000 to fund the COG trial. Gefitinib, which costs £5000

per month, is provided free to patients by AstraZeneca

as part of a grant in aid. This shows the huge benefits

clinical trials can offer patients who would otherwise

only receive palliative care. The total commercial

value of the drugs donated is over £6 million, which

illustrates the sums involved in research at this level.

Because half the patients in COG get a placebo, there

are challenges to recruiting patients for the trial.

However as one patient who entered the COG trial

said: “The choices are stark, either have a 0% chance

of getting active treatment in standard care, or a

50% chance of getting Gefitinib in the trial. It’s a nobrainer.”

This trial has now randomly selected 200 patients

to placebo or Gefitinib tablets and 16 patients have

entered the trial. These patients are supported by

research nurses and the Greater Midlands Cancer

Research Network. This gives a £350 000 annual grant

for cancer research to New Cross Hospital. The COG

trial runs for another two years and aims to recruit 450

Phase Number of

patients

I 10-30 Start at low dose and

increase dose till strong

side effects occur,

maximum tolerated dose

(MTD)

II 25-75 Treat patients with a given

type of cancer with a dose

lower than MTD

III 400-4000 Discover if the new

treatment prolongs

survival compared

to old treatment in a

randomised trial

Design Objective

patients at 50 major cancer hospitals across the UK.

This isn’t the only research Professor Ferry’s team

have conducted into upper GI cancer.

New Cross was also the leading UK hospital for the

TOGA trial which introduced Herceptin into gastric

cancer treatment, increasing patient survival from 12

to 16 months. Other trials have also been conducted

with new taxanes, including the drug Everolimus.

Everolimus is used to prevent organ rejection after

transplantation, but is now being tested in the

GRANITE study into stomach cancer.

The GRANITE study complements the COG trial very

well, because it’s for patients with cancers further

down the upper GI tract in the stomach. It is similar

to COG but uses the mTOR inhibitor Everolimus,

which is taken as a daily tablet. Like Gefitinib,

this new medicine has very few side effects. The

GRANITE trial is run by CRUK in collaboration with

the pharmaceutical company Novartis. At New Cross,

nine patients have been randomised in the trial out of

16 across the UK. New Cross is the leading UK centre

in this trial and in the top 10 highest recruiting centres

in the world. Professor Ferry said: “This is the first

ever second line study in stomach cancer patients

who are often very ill. Because Everolimus is so well

tolerated, patients can be treated and we’ve already

seen tumour shrinkage in some of our patients and

improved quality of life.”

“This work is only possible with the help of an

effective Research and Development team and

dedicated research nurses and data managers,”

explained Professor Ferry. “At New Cross, we’re

fortunate to have nurses who are very experienced

in highly demanding clinical trials. These nurses don’t

just help with trial-related tests. They also provide

vital support to our patients and their families.”

Define side effects

and measure

amount of drug in

blood

Does the drug have

any activity?

Does the drug

prolong life?

New Cross is now

recognised as one of

the leading cancer

centres in the UK for

clinical research into

upper GI cancers.

Patients are referred

from hospitals around

the country, and email

opinions from colleagues

and even patients are

increasing. However, as

Professor Ferry points

out, the Trust is only at

the beginning of the

journey in applying new

personalised medicine in

this disease area: “There

is no guarantee that the

COG or GRANITE trials will

deliver breakthroughs,”

says Professor Ferry. “If

these trials are negative

then we will move

forward with our next

experiment because

research is constantly

evolving. A follow on trial

to COG is already being

planned.”

Sister Kay Hadlington, Sister Davina Warrender,

Professor David Ferry and Senior Sister Kelly

Papavarnava

Senior Sister Kelly Papavarnava

Professor David Ferry and Senior Sister Kelly

Papavarnava

10


TCS

11

Why is this happening?

Transforming Community Services, (TCS), is a National

programme of change.

It’s been introduced to achieve greater service

integration through a structural reform of community

services provided directly by the PCTs. The reform

aims to modernize the delivery of these services.

It will do this in a number of ways by:

• Enabling and empowering staff to free their time

to care for patients

• Empowering clinicians to help shape the future of

community services

• Making services more sustainable and flexible

TCS is an aspiration of the NHS Next Stage Review and

the new White Paper: Liberating the NHS. It means

that the commissioning of health care will be designed

to promote high quality standards of care.

The Next Stage Review sets out the vision for primary

and community care. It gives people more choice

and control over their own health care and promotes

healthy lifestyles and equity for all.

Transforming

Community

Services ong>Updateong>

What will TCS achieve?

TCS aims to improve community services so they

can continue to provide modern, personalised and

responsive care. It also means that every Primary Care

Trust in England will no longer be a direct provider of

community care services.

What is the Trust’s Role in this?

The Trust is very proud in the way it has grown its

services and now provides secondary and tertiary care

for people across the West Midlands.

The majority of people living in Wolverhampton see

us as their local hospital and first choice for health

care. Because of our long history of working together

to improve services for people, it seemed sensible to

integrate with the provider services of WCPCT.

What have we been doing?

There are several themes we need to look at as we

prepare for integration. These are:

• Due diligence

An investigation or audit of a potential investment

• Corporate services review

How to support systems by using existing

corporate skills and workforce

• HR arrangements

Vacancy management and policies and procedures

specific to TCS

• Shadow monitoring arrangements

Services working alongside each other to prepare

for the transfer.

To help us meet the Government’s deadline of 1 April

2011, we will be introducing shadow arrangements

during the Autumn. This will see services beginning to

work alongside those within WPCT, in preparation for

the formal transfer date on 1 April 2011.

How will we keep you informed?

We will continue to keep you informed through our

internal communications.

This includes regular newsletters, your TCS intranet

page and a series of frequently asked questions, which

will be updated regularly.

If you have any queries, please send them to:

samanthaturner@nhs.net

The Trust welcomes this opportunity to put into

practice the integrated approach to care we’ve been

developing for some time,” says Chief Executive,

David Loughton CBE.

“We work very closely with services in the WPCT

and these proposals represent a real opportunity to

further develop the care we offer to the people of

Wolverhampton and beyond. We will also ensure that

our excellent standards continue whilst the transfer

goes through.”

R&D

Developments

Last year, Research and Development achieved an

impressive £3.7 million turnover here at the Trust.

The team works closely with a number of key partners

to facilitate the advancement of knowledge, treatment,

care and modernisation through research and innovation

activity which will, ultimately, benefit our current and

future patients. Key partners include the West Midlands

Comprehensive Local Research Network, Greater

Midlands Cancer Research Network, Stroke Research

Network and Medicines for Children Research Network.

What we do

The Trust has been a very successful partner site for

leading researchers across the NHS and Industry to

validate new methods, treatments and knowledge

and our patients have been very keen to explore such

opportunities as part of their treatment planning. We

are a developing our capabilities in developing our own

research trials and this is a very exciting time for the

Trust as leading clinicians, nurses and allied healthcare

professions develop professionally and lead the way for

direct patient improvements through research.

The Directorate has also achieved credit for its

innovation management work with staffs, academia,

industry and patients. The R&D Directorate has

championed innovators to local and national recognition.

Products which have been supported, developed and

commercialised by the Trust via R&D are now being

commercially sold back into the NHS, Private healthcare,

on-line and via prescription.

In broad terms, Research and Development is dedicated

to reducing barriers to improving patient care by seeking

research and innovative opportunities which will improve

knowledge, care, treatment and choice.

“Research is incredibly important within a hospital,” says

Directorate Manager of Research and Development,

Yvonne Hague. “For some patients standard treatment

is not effective and patients will ask “what research

is available”, and it becomes more important to seek

alternative options in the hope of preventing, improving

or curing their illness”

Mouletec Cushion

The R&D Directorate work to very strict protocols and

regulations to protect the patient confidentiality and

healthcare whilst involved in a trial. Staff from across

the Trust receive specialist training to conduct or take

part in any trials.

Pioneers

The Trust has achieved several ‘firsts’ in Research and

Development as well. “We were behind the introduction

of the first patient innovation Ortho-glide. We were also

the first Trust to feature a product in the NHS catalogue

called Hook-it. This led to the Hook-on, followed by

Femmax and the Mouletec cushion and mattress.

An Orthoglide is a simple lower limb exerciser device

that aids rehabilitation after trauma or surgery to the

knees or hips.

Femmax

The Femmax is a dilator initially developed to address

the clinical risks for women who acquire vaginal

adhesions following gynaecological surgery and

radiotherapy treatment. Under clinical supervision it

has since been used for women who wish to train their

vaginal and has proved highly beneficial.

And the Mouletec technology helps even the pressure on

buttocks and upper legs. In tests, compared with other

seats, Mouletec seats not only provide extreme comfort

but also improve lower limb venous blood flow.

Who we are

R&D Director – Dr. James Cotton

R&D Directorate Manager – Mrs Yvonne Hague

Project Manager – Mrs Lorraine Jacques

Research Nurse Manager – Mrs Pauline Boyle

Business Support Manager – Mrs Kate Lees

R&D

12


MRSA

13

MRSA - Dispelling the myths

“Much confusion surrounds

this issue, which is regularly

featured in the National

media,”

Many people have asked for better clarification

concerning MRSA. We decided to try and dispel

some of the most common myths surrounding MRSA

infection in hospitals.

“Much confusion surrounds this issue, which is

regularly featured in the National media,” explains

Director of Nursing and Midwifery at The Trust,

Cheryl Etches. “We wanted to respond to people’s

concerns by sharing clearer information with the local

community about what exactly MRSA is. The thing

that seems to cause most confusion is the difference

between MRSA infection and MRSA bacteraemias.

MRSA bacteraemia is a serious infection of the blood.”

MRSA bacteraemia is one of the indicators used to

measure how well hospitals perform in preventing

healthcare associated infections. The number of blood

infections caused by MRSA count towards a national

surveillance scheme. It is these serious infections,

known as MRSA bacteraemias, that are used to rank

hospitals in England in terms of their ability to control

the spread of infections.

Not everyone who has MRSA gets an infection with

it. In fact, the vast majority of people who have MRSA

living on their skin, or in their bodies, are totally

unaware of it and will never suffer any ill effects. A

small number of people do get infections caused by

MRSA and in hospital these most commonly are skin

infections in relation to surgical wounds or other

breaks in the skin, like chronic wounds.

“If these infections are treated with the correct

antibiotics they should not progress to become

serious MRSA bacteraemia infections,” added Cheryl.

“Although there have been many people in New Cross

Hospital who’ve been found to be carrying MRSA

harmlessly over the past year, and there have been

a number of actual infections caused by MRSA that

have required antibiotic treatment of the infection,

our Trust has had no MRSA bacteraemia infections

for more than a year now. This is a remarkable

achievement for a hospital of this size, which carries

out such a wide range of complex procedures,” said

Cheryl.

Most people found to be carriers of MRSA do not

have infections with MRSA. In Wolverhampton, 800

people were MRSA positive during 2009 – 100 of

which were patients at New Cross. The remaining

number were already positive on their admission

or were not in New Cross at all. This compares with

904 new MRSA carriers found in 2008. It is vital

that people understand that this relates just to the

presence of MRSA and not serious illness with blood

stream infection.

“About one in three of us carries a Meticillin sensitive

strain of Staphylococcus aureus bacteria in our nose,

or on the surface of our skin, especially in folds like

the armpit or groin, without developing an infection,”

explains Cheryl. “The Meticillin resistant strains of

Staphylococcus aureus, (that is MRSA), are no more

dangerous than these very common sensitive strains,

but are just more difficult to treat if an infection does

develop. However, treatments are available for

infections caused by all strains of MRSA.”

All NHS patients going into hospital for a relevant

planned procedure are screened for MRSA

beforehand. Patients admitted as an emergency are

screened on admission as well. This helps hospitals

reduce the chance of patients getting an MRSA

infection or passing MRSA on to another patient.

Common MRSA infection myths

1. What exactly is MRSA?

MRSA stands for Meticillin Resistant Staphylococcus aureus,

which is a common skin bacterium that is resistant to a range of

antibiotics. It is resistant to the antibiotic Meticillin, which is a

marker antibiotic used in the laboratory. Resistance to Meticillin

indicates that the bacteria will be resistant to many other

antibiotics, particularly those related to the penicillin class of

antibiotics.

2. MRSA is one of the brand new ‘superbugs’ that the health care

system isn't telling anyone about.

MRSA was first described 50 years ago, soon after the

introduction of the antibiotic Meticillin. It has spread over the

years in hospitals and the community.

More cases of community-acquired MRSA are showing up than

in previous years. Despite its resistance to many antibiotics,

there are still antibiotics available capable of treating all strains of

MRSA, so the classification of MRSA as a ‘superbug’ is dubious.

Research is currently being done to determine why it's cropping

up more frequently in the community.

3. We hear that all infections are preventable.

No, not all infections are preventable. The aim of the Trust is to

minimise the spread of germs that can cause infections and have

good clinical practices in place to reduce the number of infections

that do occur.

4. MRSA is the sole problem in hospitals today

No, this is not true. MRSA accounts for a small proportion of

hospital infections.

5. MRSA is a ‘killer bug/super bug’

This is not true and overstates the facts concerning MRSA. There

are many bugs much worse than MRSA, and the majority of

people who have MRSA on their skin or in their body suffer no ill

effects from it.

6. That health care-associated infections have escalated beyond

control

National surveys have shown that the number of patients in

hospital who have a healthcare associated infection has actually

decreased in recent years, and numbers are continuing to fall.

7. We hear the UK is worse than everywhere else

Not true. The rates of infection are similar to most countries

in Europe. The UK has one of the best infection surveillance

systems in the world and comparison with other countries where

surveillance is not as good will make the UK look worse than it

actually is.

8. That hospitals cause MRSA and other infections

Most infections that arise in hospitals arise from organisms

present in our own bodies at the time of admission to hospital.

14


Staff Shout

15

Trust

Midwife's

Charity

Bike Ride

A specialist midwife from the

Trust recently tested her stamina

and endurance, in a London

to Paris bike ride for Best

Beginnings, a National child

health charity. Amanda Costello,

who heads up the maternity unit

on breast feeding, did the

country-to-country bike ride

between 12 and 15 September.

She covered 180 miles (300km) in

just three days, cycling through

the steeply undulating countryside

towards the south coast of

England, before entering France

by ferry. Amanda completed the

challenge to raise money for child

health charity Best Beginnings.

”Riding from London to Paris

was really tough,” said Amanda.

“It tested my physical and mental

endurance. But it’s for a cause

close to my heart. As a midwife

with responsibility for Infant

feeding here at New Cross, I

recognise the importance of

increasing the number of babies

who receive their mother’s milk

and how this can help reduce

health inequalities.”

Amanda Costello prepares for her

biking adventure, watched by her

colleagues from the New Cross

Maternity Unit

"Riding from

London to Paris

was really tough"

Neonatal

Unit Receives

Donations

Two families have kindly donated money to

the Trust’s Neonatal Unit.

The unit was presented with a cheque for

£500 by a couple from Brownhills.

Dorothy and Terry Willetts are members

of the International Appreciation Society,

which raises funds for good causes around

the globe. The couple wanted to donate

money to the unit as they have supported it

before: “We’re really pleased to be able to

help out in this way,” explained Mr Willetts.

“Our society meets just once a year, and

over 12 months we hold raffles, do car

boot sales and other activities to help raise

money. We often bring in baby clothes to

the Neonatal ward, so it’s nice to be able to

do this and give something back to a much-

Footy team

tackles NHS

Tournament

HAFAS is a Healthcare 5-Aside Soccer

Tournament. It’s a non-profit making,

charitable event, with 10% of the entry fees

going to a nominated charity.

All health care trusts are invited to take

part in the tournament, held every June.

The event, which runs over two days,

alternates between venues in Manchester

and Nottingham.

needed facility that’s so close to home.”

“In the current climate, we’re extremely

fortunate to receive this donation from Mr

and Mrs Willetts, who’ve clearly given up

their own valuable time to help others,” said

Kim Ong, Neonatal Co-ordinator at the Trust.

“This money will go a long way towards

maintaining the high level of service and

care here on the ward that we are so proud

of.”

A Family Affair

And it was a real family affair when two

generations took part in a gruelling triathlon

last September, raising an impressive £1,300

for the neonatal unit.

The Trust is already looking to submit a

team again for next year. “As well as being

able to represent the hospital, it’s also a

social event and a chance to meet other

Trusts from across the UK,” said organiser,

Laky Singh, a porter at the Wolverhampton

Medical Institute.

This year a combined team of players from

New Cross and Walsall Manor hospital took

part. “Even though we didn’t get very far,

Terry and Dorothy Willetts hand over a cheque for £500.

Photograph supplied by Kim Ong

Grandparents, Julie and Martyn Davis,

together with Auntie, Jodie Davis, did the

triathlon as a thank you for the skill, care

and support the family received for Jaden

Lei Davis. Jaden was born in September

2008, at 30 weeks and weighed just 3lb 11oz.

He is now doing really well.

When Jaden was discharged, £1843.00

was also donated by the Wolverhampton

Development Football Team on behalf of

Jaden. The club has close contact with

Jaden’s other Grandad, John Norwood and

his Uncle, Callum Norwood.

Huge thanks for your contributions to the

unit!

Front row Matt Piper, Laky Singh, James Bevan, Hemel raja, Back row Amrik Singh, Craig Nicholls, Raj Samra,

Manish Buchar. Photograph supplied by Laky Singh

it was a good learning curve and everybody

really enjoyed it,” said Laky. “I’m looking to

enter at least one team next year, so we’ll

need a minimum of 10 players and I arrange

everything, from entry through to the travel

and hotel arrangements.”

Any staff wishing to be on the team will get

an opportunity to do this in 2011. Training for

the event begins around February/March.

16


Staff Shout

17

Trusts 'Marathon'

Activities for

Dementia care

Trust Staff got ‘on their marks,’ to raise funds towards dementia care in

September, when several people took part in the City’s half marathon.

Staff from the Kings Fund Team, which

is cash granted by the Department of

Health, ran, walked, or cycled the 13.1

mile route around the City on

5 September.

The money raised will help towards

much-needed improvements for

those suffering from dementia and

their families. A small garden area

and treatment bays in the Emergency

Assessment Unit are specifically going

to be introduced by this team.

The Department of Health’s Professor

Jane Gilliard paid a visit to the Trust to

meet the team and discuss plans for the

project here in Wolverhampton.

As Programme Manager for the

National Dementia Strategy, Prof.

Gilliard was keen to find out more

about the Trust’s plans thanks to

money from one of its National

projects called: Enhancing the Healing

Environment (EHE).

The award-winning EHE programme

encourages nurse-led teams to work in

partnership with patients, to improve

the environment for the delivery of

care.

This year, members of the team

decided to do their bit to raise even

more cash towards improvements, by

taking part in the half marathon.

Matron Karen Bowley, who is leading

the project, explained what people will

be doing: “Some people are running

the whole distance, whilst others are

walking part of it, or cycling some

of the route. We all agreed this was

an ideal opportunity to add to the

pot whilst also raising the profile of

dementia and the services we will soon

have available to help cater for this

complex condition.”

The Trust’s wider plans for improving

dementia services are supported by

the Strategic Health Authority and the

Wolverhampton City PCT. These include

a dedicated ward for treating patients

with dementia – designed specifically

with their needs in mind and a ‘floating’

team, led by a consultant nurse, to

specialise and deal with referrals for

those with dementia.

Meanwhile the King’s Fund Team

is aiming to raise several thousand

pounds thanks to their marathon

activities.

Anyone wishing to make a donation can

contact Joanne Rogers on

Tel: 01902 307999 x4117 email:

joannerogers@nhs.net

Second left, Prof. Jane Gilliard,

with the Chief Executive and some

of the staff taking part in the half

marathon.

'this was

an ideal

opportunity

to add to the

pot whilst

also raising

the profile of

dementia'

New patient care pathway

launches

The Liverpool Care

Pathway for patients

who are dying is

an integrated care

pathway. It aims

to provide the best

quality care to patients

at the end of their

life. It does this by

introducing continuous

improvement and

quality into the care

of the dying, as well as

providing support and

guidance to staff.

The Liverpool Care

Pathway, Version 12,

is now being launched

across the trust,

following its national

New Catering

Facility Opens

The new £3 million catering unit at New Cross

Staff at the launch of the new care pathway in September

launch last December.

To begin with, this will

be implemented on

wards D20, D19 and

the Deansely ward,

before being rolled out

across the Trust. The

Trust also takes part in

a National audit which

helps us look at how

effectively we’re using

this pathway.

Susanne Bradley is

facilitating this and will

be joined shortly by

Becky Hilse, providing

training to all staff of

all disciplines. Susanne

can be contacted for

information and advice

on bleep 7374.

Further infomation

is available for health

professionals and

staff on the intranet

at: http://intranet/

departments/end_of_

life_care.aspx

A new £3 million food production facility has opened at the Trust.

The two-storey, state-of-the-art building replaces the former kitchen facility in

a block that was almost 50 years old. It was built to introduce a more effective

cook and chill production unit, and improve the quality of food and service

received by patients at the Trust.

Among the new facilities are a 1,001 sq metre kitchen which will include walk

in fridges and freezers and comprehensive food production areas. It will also

mean a new way of cooking and delivering the food on to the wards. Ward

hostesses will deliver the chilled food, where it will be cooked in a special

trolley unit on each ward. The new cooking system will avoid food becoming

overcooked or failing to stay hot and patients will no longer be restricted to

precise eating times.

A brand new menu has also been designed, which will accommodate special

dietary requirements. Patients will no longer have to select what they want in

advance. Instead, they will be able to choose what they want when the cooking

unit arrives on the ward at mealtimes.

“Our new catering facility means our patients can benefit from the highest

quality food and have far more choice and flexibility when it comes to

mealtimes,” said Martin Cantor, Catering Project Manager. “Quality food and

a quality service will help us to enhance the patient’s overall experience whilst

in our care.”

New Nursing Team

Unveiled

A new nursing team aimed

at raising awareness of

blood clots has begun

at the Trust. Venous

Thromboembolism (VTE) is

a serious medical condition

caused by the formation

of blood clots. A bit of this

blood clot can break off

and travel in the veins to

the lungs, where it causes

a clot on the lung, called a

pulmonary embolus, which

can be life threatening

Sarah Cotterill and Evie

Ambrose started at

the Trust’s Emergency

Assessment Unit in

September, in an effort to

reduce and prevent such

conditions. A special launch

event was held for staff to

explain why VTE prevention

is so important and how

they can help to improve

patient safety.

Children’s Ward Receives

Book Donation

Our Children’s Wards

has been presented with

some new books thanks

to a donation from the

WHSmith Trust. This

summer, WHSmith Trust

and PLC are donating books

to 10 hospitals across the

UK. Each hospital will

receive 300 books, which

will create a new library

or supplement an existing

one. Pete Gibbons, Head

of Commercial Services

at the Trust, said: “We’re

delighted that WHSmith

has chosen our hospital in

Wolverhampton for this

donation. It is a fantastic

initiative and one which

will bring enjoyment and

benefit to many of our

patients.”

Orthopaedic Team

Shortlisted for Award

The Trust’s Orthopaedic

Team has been shortlisted

for the Efficiency Initiative

of the Year at this Year’s

HSJ Awards.

The team made it on to the

shortlist after introducing a

series of initiatives for using

its theatres – resulting

in savings of around

£1.2million.

Some of the measures

included creating six

theatre sessions each

week; conducting minor

surgical procedures in

treatment rooms to free

up the theatres and using a

new booking tool to plan in

more accurate theatre time

for each consultant.

After presenting their

entry to a judging panel in

October, the winners will

be announced at an awards

ceremony in November, at

London’s Grosvenor Hotel.

NHS Visit Praises Patient

Safety

The Trust received a visit

from a leading figure of the

NHS last week, where they

showed him their widely

renowned approach to

maintaining patient safety.

Sir Bruce Keogh is the

Medical Director of

the NHS. He came to

Wolverhampton to see the

approach of the Trust and

why it has such an enviable

reputation as a leading

hospital in the prevention

and reduction of infection.

“To go over 445 days

without MRSA infection is

something I would never

have thought possible

only three years ago,”

said Mr Keogh. “This

hospital shows a relentless

approach and enormous

pride in how it continues to

tackle infection prevention.

Patients can be genuinely

reassured by the fact that

the Trust actually reduces,

rather than introduces

infection here.”

Retail Survey Winner

Thanks to everyone who

took part in our recent

Retail Survey.

The excellent response

we’ve had from you means

we have lots of information

to help shape and influence

our Retail Strategy.

As the project progresses

we’ll keep you informed

about these new and

exciting developments.

The winner of our prize

draw was Clinical Trial

Co-ordinator, Anna Grant.

Congratulations Anna!

You’ve won £50 worth of

High Street vouchers

18


History

19

The Legacy of

Florence Nightingale

Florence Nightingale

"...we can

see a direct

link between

the sort of

things we have

introduced and

how Florence

herself

influenced

such key

aspects of the

profession.”

The Trust has marked the 100th anniversary of Florence Nightingale’s

death with a look back at how nursing has evolved since the era of

Britain’s legendary nurse.

Florence Nightingale became a living

legend as the 'Lady with the Lamp'.

She led the nurses caring for thousands

of soldiers during the Crimean War

and helped save the British army from

medical disaster.

This was just one of Florence's many

achievements. She was also a visionary

health reformer, a brilliant campaigner

and the most influential woman in

Victorian Britain and its Empire, second

only to Queen Victoria herself.

Nightingale died in 1910 at the grand

age of 90.

“Since Florence Nightingale’s

death, our hospital and some of our

community has seen two world wars,

a series of epidemics and, of course,

the creation of the NHS,” said David

Loughton, CBE, Chief Executive of the

Trust.

“A huge part of this change has been

the role of our nurses across the

generations. Florence had strong

principles about cleanliness, ward

Designed and produced by the department of Medical Illustration and Graphic Design, New Cross Hospital, Wolverhampton, WV10 0QP - Tel: 01902 695377

design and standards of nutrition and

hydration. Today, we can see a direct

link between the sort of things we have

introduced and how Florence herself

influenced such key aspects of the

profession.”

The Trust continues to be one of the

Nation’s showcase hospitals for patient

safety, with more than 90 other Trusts

having been referred to them to learn

from their approach. It has also been

free of MRSA infections of the blood

for well over a year now – and is looking

to launch a range of new patient safety

systems in the near future.

“We like think our new care bundle for

dementia patients and the forthcoming

launch of our new dementia ward are

also innovations Florence Nightingale

would have approved of. We want

to bring nursing back to being all

about care and the personal touch

– something the woman herself was

extremely passionate about.”

One of the wards at New Cross

just after the war

More magazines by this user
Similar magazines